Gemma Ryan
About Gemma Ryan
Gemma Ryan is the Manager of Formulation Development at Precision NanoSystems Inc. in Vancouver, British Columbia, where she has worked since 2021, bringing extensive experience in nano-medicine development and a PhD in Pharmaceutical Science from Monash University.
Work at Precision NanoSystems
Gemma Ryan has been serving as the Manager of Formulation Development at Precision NanoSystems Inc. since 2021. In this role, she oversees the formulation development process and contributes to the advancement of nano-medicines. Prior to her current position, she held multiple roles within the company, including Project Team Lead from 2020 to 2021 and Formulation Scientist from 2018 to 2020. Her tenure at Precision NanoSystems has allowed her to leverage her expertise in formulation and downstream processing.
Education and Expertise
Gemma Ryan holds a PhD in Pharmaceutical Science from Monash University, where she also completed her Bachelor of Pharmaceutical Science, specializing in Formulation Chemistry. Her educational background provides a solid foundation for her extensive hands-on experience in the development of nano-medicines. She possesses strong expertise in physical characterization, in vitro analysis, and in vivo pharmacokinetics, pharmacodynamics, and biodistribution.
Background
Before joining Precision NanoSystems, Gemma Ryan worked as a Post Doctoral Fellow at the BC Cancer Agency from 2015 to 2018. She also completed her PhD candidacy at Monash University from 2011 to 2015. Her academic and research experiences have equipped her with a comprehensive understanding of pharmaceutical sciences and the development of innovative therapeutic solutions.
Professional Experience
Gemma Ryan has accumulated significant professional experience in the field of pharmaceutical sciences. Her roles at Precision NanoSystems included serving as a Formulation Scientist and Project Team Lead, where she contributed to various projects focused on nano-medicines. Additionally, her post-doctoral work at the BC Cancer Research Center further enhanced her research capabilities and understanding of cancer therapeutics.